Abstract
The COVID-19 pandemic has affected all individuals across the globe in some way. Despite large numbers of reported seroprevalence studies, there remains a limited understanding of how the magnitude and epitope utilization of the humoral immune response to SARS-CoV-2 viral anti-gens varies within populations following natural infection. Here, we designed a quantitative, multi-epitope protein microarray comprising various nucleocapsid protein structural motifs, including two structural domains and three intrinsically disordered regions. Quantitative data from the microarray provided complete differentiation between cases and pre-pandemic controls (100% sensitivity and specificity) in a case-control cohort (n = 100). We then assessed the influence of disease severity, age, and ethnicity on the strength and breadth of the humoral response in a multi-ethnic cohort (n = 138). As expected, patients with severe disease showed significantly higher antibody titers and interestingly also had significantly broader epitope coverage. A significant increase in antibody titer and epitope coverage was observed with increasing age, in both mild and severe disease, which is promising for vaccine efficacy in older individuals. Additionally, we observed significant differences in the breadth and strength of the humoral immune response in relation to ethnicity, which may reflect differences in genetic and lifestyle factors. Furthermore, our data enabled localization of the immuno-dominant epitope to the C-terminal structural domain of the viral nucleocapsid protein in two independent cohorts. Overall, we have designed, validated, and tested an advanced serological assay that enables accurate quantitation of the humoral response post natural infection and that has revealed unexpected differences in the magnitude and epitope utilization within a population.
Funder
National Research Foundation South Africa
Hamad Medical Corporation
Subject
Virology,Infectious Diseases
Reference40 articles.
1. Rolling Updates on Coronavirus Disease (COVID-19)https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
2. Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV)
3. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
4. How Two Tests Can Help Contain COVID-19 and Revive the Economy;de Walque,2020
5. Coronavirus Disease (COVID-19) Outbreak Situationhttps://www.who.int/emergencies/diseases/novel-coronavirus-2019
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献